Issue 16 – Autumn 2011

Keys to successfully entering the US market
M&A drop as buyers look to minimise risk
Crowdsourcing pharma drug development
Monetising your non-strategic assets
Product pipeline trends bring fresh optimism
Deal watch

Read more HERE

Issue 15 – Summer 2011

Pharmaceutical market at a turning point
An alternative future for the pharmaceutical industry
Could successive demergers see the industry turn away from consolidations
Patent box proposals
The valuation high ground
The secrets of building a successful coalition
Deal watch

Read more HERE

Issue 14 – Spring 2011

The end of free pricing as we know it
Protecting margins in an unpredictable market
SPCs: a simple means of extending patent protection?
Overcome the obstacles to effective renegotiation
Implications of the UK Bribery Act 2010
Deal watch

Read more HERE

Issue 13 – Autumn 2010

Competition Law and the Relevance of Market Shares
A new paradigm for frugal healthcare innovation
Diving into the Pharmaceutical Patent Pool
The future of fixed combination product development
Deal Watch

Read more HERE

Issue 12 – Summer 2010

Co-marketing – a successful cooperation model
Trends in pharmaceutical dealmaking
Plan B : When negotiations fail
Follow-on Biologics
Finding new products to license
Book review
Deal Watch

Read more HERE

Issue 11 - Spring 2010

New Oilfields in Pharma
Licensing Deal Valuation
A Revolution in Healthcare
Innovation in Negotiation
Paediatric Legislation – A Potential Roadblock to New Drugs in Europe
Deal Watch

Read more HERE

Issue 10 – IPLS 2009

The Development of Personalised Medicine
Survival of the Fittest: How the financial Crisis is Saving Big Pharma
Creating Value with Alliance Management
Difficult Negotiations with Difficult Negotiators
Pharma at the Crossroads

Read more HERE

Issue 9 – Autumn 2009

PLG News
European Commission Pharmaceutical Sector Inquiry
Managing Growth by Minimising Risk
Regulatory Data Exclusivity in the European Union
Diversified or Dead?
Negotiating with Governments
Evaluating Licensing Opportunities

Read more HERE

Issue 8 – Spring 2009

PLG News
Strategic options for getting the most out of late-stage licensing deals
Trends in the therapeutic area focus of leading pharmaceutical companies
Royalty recovery and audits
Managing and motivating negotiators
Prepare to meet your partner
Book review and author review

Read more HERE

Issue 7 – Winter 2008

Partnerships: Necessary but not sufficient for the future of the Pharmaceutical Industry
The perfect business development organisation? Comparison of theory and practice along the pharmaceutical licensing process
The Reverse Start-Up Model: An organisational approach to bridge the innovation gap
Opportunities and challenges in licensing
Creating real value in pharmaceuticals. Driving business development through portfolio strategy

Read more HERE

Issue 6 – Autumn 2008

Venture Capital and Not for Profit Interaction in Medical Innovation: Establishing an Equitable Solution?
The Changing Face of R&D in the Future Pharmaceutical Landscape
Negotiating Clinical Trials: The Process of Building and Sustaining Trust or How do Cats Share the Milk?
Book reviews
The Art of War Gaming

Read more HERE

Issue 5 – Spring 2008

PLG news
The interface between the pharmaceutical industry and academia in the UK
Cultural aspects in managing development and marketing alliances
The Pharma Negotiator: a style profile
Negotiating boomerang deals
Opportunities and barriers in the biosimilar market: Evolution or revolution for generics companies?

Read more HERE

Issue 4 – Autumn 2007

Consolidation in the generics sector
Mind the gap: integrating business development
Communication during cross-cultural negotiations
How inaccurate self-reporting affects your business liability
Competitive intelligence: when ignorance is not bliss
Termination: intellectual property and related issues
Book reviews

Read more HERE

Issue 3 – Spring 2007

Negotiating performance clauses in licensing contracts
Global pricing strategies for pharmaceutical goods
Drug delivery
Product life-cycle management through second indications – a case study
Data protection for pharmaceuticals in the European Union
‘Mind the gap’: how to negotiate with innovators and scientists
Patent pools – a practical guide

Read more HERE

Issue 2 – Autumn 2006

The business development professional: an evolving breed
The key to successful collaborations: rigorous and independent due diligence
Equity investments in licensing deals
Co-marketing in Italy: a history of success
Co-ownership of intellectual property rights: a warning for the unwary
How organisations negotiate: managing a love-hate relationship
Life-cycle management under scrutiny

Read more HERE

Issue 1 – Spring 2006

Issues arising from the TGN1412 clinical trial
IP valuation in pharmaceuticals and biotech
Legal Implications of different licensing structures
Negotiating with the tribes
Licensing opportunities in China’s emerging bio-pharma industry
Building ethical and generic partnering deals in Poland
The great leap for small and medium-sized pharma companies

Read more HERE

Order Back Issues HERE